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Abstract
Septic embolism is a relatively common and potentially severe complication of infective 
endocarditis (IE). Septic emboli (SE), most often described as consisting of a combination 
of thrombus and infectious material—either bacterial or fungal—can be caused by hema-
togenous spread from virtually any anatomic site; however, it most commonly originates 
from cardiac valves. During the past two decades there has been a confluence of various 
risk factors that, both alone and in combination, led to greater incidence of both IE and 
SE, including increasing population age, greater use of prosthetic valves, implantation of 
various intracardiac devices, escalating intravenous drug use, and the high incidence of 
healthcare associated infections with antibiotic resistant microorganisms. From a clini-
cal standpoint, SE can present at any time during the course of IE and may even be the 
initial presenting sign. SE may affect virtually any location in the human body, but some 
organs (e.g., liver, spleen, brain) and anatomic regions (e.g., lower extremity) tend to be 
more frequently involved. The most important aspect of management involves prompt 
recognition and proactive therapeutic approach. Given the broad spectrum of clinical 
presentations, symptoms and complications, SE can be challenging to diagnose and treat. 
Following the identification of SE, appropriate antibiotic coverage should be immediately 
instituted followed by supportive and/or interventional management, depending on the 
severity of presentation and the associated complications. In this chapter we explore the 
pathophysiology, anatomic origins, diagnostic tools, therapeutic measures, and new 
developments in SE, focusing predominantly on bacterial infections of cardiac origin.
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1. Introduction
The collective understanding of infective endocarditis (IE) has changed significantly since 
its early characterization by Sir William Osler [1, 2]. In most low-and-middle income coun-
tries, rheumatic fever accounts for approximately two-thirds of all endocarditis cases [3–5], 
whereas in developed countries it is responsible for less than 10% of instances [6]. Over the 
past decade the incidence of IE has been increasing, with a recent study showing an overall 
increase of >30% between 2000 and 2011 [7]. The American Heart Association identified IE 
and associated complications as a major source of cardiovascular disability [8].
This surge in IE has been linked, in part, to recent medical advances, including increased use 
of implantable cardiac devices and a growing population of patients with chronic comorbidi-
ties [5, 9, 10]. Moreover, 10–35% of newly diagnosed cases of IE are thought to be healthcare 
associated infections, and hospital-acquired IE attributable to sources other than cardiac sur-
gery is an emerging problem with mortality as high as 30–50% [11, 12]. The above observa-
tions can be explained, to some degree, by increases in antibiotic resistance including greater 
incidence of methicillin-resistant Staphylococcus aureus (MRSA), and higher prevalence of 
comorbidities in an increasingly aging population [2, 5, 12, 13].
In terms of intravenous drug use, injectable heroin has seen significant escalation [14, 15], 
with an associated incidence of IE growing by 58% between 2000 and 2013 [14]. In addition 
to the disease burden on individual patients and their families, the health-care system is fur-
ther taxed with managing this difficult and expensive to treat population [14, 16]. Finally, it 
is important to recognize that recent years have seen IE presentations becoming more acute 
in nature, making diagnosis and treatment more challenging at times [5, 17, 18]. Among key 
complications of acute IE, the development of potentially devastating septic emboli (SE) may 
be seen. In this chapter, we will focus on the pathophysiology, diagnosis, and management of 
SE in the context of IE, using a systematic anatomic approach and outlining some of the most 
recent developments in this fast-changing area of cardiovascular infectious disease.
2. Pathophysiology of septic emboli
When discussing the pathophysiology of emboli of cardiac origin, one must consider both non-
infective (Libman-Sacks or autoimmune, Marantic or related to wasting illnesses such as can-
cer) and infective (e.g., bacterial or fungal) endocarditis [19–21]. As an overarching theme, any 
condition that results in structural “damage or alteration” of cardiac valves has the potential 
to trigger an inflammatory reaction leading to the formation of valvular “vegetations” and 
thromboembolic complications [22]. In contrast to non-infectious valvular etiologies which 
lead to sterile emboli, IE has the potential to produce SE which typically are composed of 
a conglomerate of infectious organisms, inflammatory cells, platelets and fibrin [23]. In con-
trast to non-infectious emboli, SE have the potential to result in both vascular compromise and 
hematogenous spread of infection [24–26]. Evidence shows that as many as 50–82% of patients 
with IE may be affected by some form of SE, including both symptomatic and sub-clinical 
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 presentations [27–29]. In terms of valvular propensity for systemic (non-pulmonary) SE devel-
opment, mitral valve is the most commonly involved [10, 30].
The genesis of SE is predicated on the appearance of a thrombus in a critical cardiac (usually 
valvular, Figure 1) location. This is usually associated with the presence of infected pacemaker 
leads, prosthetic valve, or some form of anatomic (acquired or congenital) abnormality of the 
native valve [30]. Bacterial species that feature specific adhesion matrix molecules are particu-
larly likely to attach onto the damaged valvular surfaces, endocardium, or exposed prosthetic 
material [30–32]. Simultaneous presence of inflamed tissue and microorganisms leads to fur-
ther accumulation of fibrin-platelet-microorganism complexes, contributing to the growth of 
infectious vegetations [33, 34]. If fragments of such vegetations—in whole or in part—are 
released into the circulation, SE is said to have occurred [5, 31, 32]. Microorganisms most 
often implicated include Staphylococci, Beta-hemolytic Streptococci, Haemophilus, Actinobacteria, 
Caridobacterium, Eikenella, and Kingella. The latter 5 are often listed under the acronym, 
“HACEK”, and are less likely to cause IE than Staphylococci and Streptococci [10, 32, 35, 36]. 
Identifying the causative organism is critical to instituting prompt treatment with the most 
appropriate antibiotics. It is important to recognize that SE may affect any organ system or 
anatomic location, although certain patterns of involvement tend to be more common than 
others. This chapter will review key clinical evidence and developments regarding the diag-
nosis and management of SE. The authors will organize the current discussion according to 
regional/anatomic considerations in order to systematize and simplify the review process.
Figure 1. An example of a large necrotic bacterial vegetation, leading to the replacement of the entire posterior mitral 
valve leaflet. A pustule can be seen in the immediate vicinity of the vegetation. Also note the normal-appearing leaflet, 
chorda tendinea, and papillary muscles of the anterior leaflet (labeled as ANT. MV).
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3. Head and neck
3.1. Brain
It is well known that there are many different central nervous system (CNS) manifestations 
of SE [37]. However, proving direct cause-and-effect relationship has been more challenging. 
Evidence suggests that septic cerebral embolic events may complicate as many as 40% of 
cases of IE, with recurrence rates for SE reaching 50% [38]. Cumulatively, manifestations of SE 
within the cerebral circulation can be divided into cerebral infarction (purely ischemic, purely 
hemorrhagic, or combined), CNS infection (encephalitis, meningitis, and abscess formation); 
and vasculopathy (vasculitis, mycotic aneurysm formation), with widely varied clinical pre-
sentations [38]. Summary of potential CNS manifestations of IE is provided in Table 1.
Involvement of SE within the CNS can be broadly categorized into cerebrovascular and non-
cerebrovascular event types. Given that approximately 20% of cardiac output is dedicated 
to supplying the cerebrovascular system, it is no surprise that the brain is among the most 
commonly involved organs in IE. In fact, it is not uncommon for a cerebrovascular event to 
precede the formal diagnosis of IE, and to be the trigger for subsequent cardiac work-up [39]. 
Consistent with the above information, the greatest risk factor for a cerebral SE is left-sided 
IE, especially when due to Staphylococcus aureus infection. For embolic strokes, symptomatol-
ogy heavily depends on the final resting point of the embolus. In one extreme case, complete 
cortical blindness followed the rupture of bilateral occipital mycotic aneurysms [40]. Even 
among patients with a limited duration of initial clinical symptoms, the risk of recurrent brain 
infarction may be as high as 80% [41]. Figure 2 demonstrates septic embolism to the brain 
originating from mitral valve endocarditis.
Among patients experiencing CNS complications due to SE, approximately 50–60% have 
ischemic lesions, with the middle cerebral artery distribution being most commonly affected 
[42, 43]. Associated symptoms may include contralateral hemiplegia, homonymous hemi-
anopia, dysarthric or aphasic speech, neglect, and sensory loss. It is difficult to differentiate 
Cerebrovascular Infections Secondary complications Rare complications
Ischemic stroke Meningoencephalitis Toxic-metabolic 
encephalopathy
Myeloradiculitis
Intracerebral 
hemorrhage
Cerebritis Seizure Spinal cord infarction
Subarachnoid 
hemorrhage
Abscess formation Headache Discitis/osteomyelitis
Mycotic aneurysm 
formation
Ventriculitis Cranial neuropathies
Ependymitis Mononeuritis multiplex
Myalgia
Adopted from Ref. [6].
Table 1. Central nervous system manifestations of infective endocarditis.
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between intracerebral hemorrhage and ischemic infarction based on clinical symptoms alone, 
and importantly, the American Stroke Association recommends against the use of intrave-
nous Alteplase in cases of suspected ischemic stroke due to SE because of elevated potential 
for hemorrhagic conversion [23]. At the time of this publication there is no specific recom-
mendation for or against intra-arterial intervention (e.g., thrombectomy) in the setting of SE 
causing large vessel occlusion and cerebral infarction, and cases should be evaluated on an 
individual basis.
Risk factors for mortality in stroke caused by SE include MRSA infection, older patient age, 
and larger vegetation size [44]. Patients with right-sided IE can also experience cerebral SE 
although it is very uncommon and occurs through the so-called “paradoxical embolus” path-
way [45, 46]. Prompt evaluation for cerebral SE is critical in any patient presenting with focal 
neurologic symptoms, and usually starts with computed tomography (CT) of the brain to rule 
out bleeding, and potentially CT-Angiography to evaluate the cerebral circulation for patency. 
One must keep in mind that, regardless of clinical symptoms, the majority of patients with IE 
have some evidence of cerebral SE on magnetic resonance imaging (MRI) [47, 48].
Patients with cerebral SE have elevated mortality rates compared to patients presenting with 
stroke from other etiologies. In fact, baseline mortality of approximately 8–9% may reach 
nearly 40% in the presence of meningitis, hemorrhage, or brain abscess [39]. In the setting of 
mild cerebral ischemia, immediate antibiotic therapy combined with valve surgery within 
48 h results in improved outcomes, including fewer systemic embolic events and more favor-
able mortality profile [49]. Recent studies also suggest that an ischemic stroke secondary to 
IE is unlikely to transform into a hemorrhagic stroke [50]. Primary indications for surgery in 
the setting of IE include the emergence of heart failure, uncontrolled infection, and embolism 
prevention [49]. Note that antithrombotic therapy is somewhat controversial in this setting. 
The American Heart Association guidelines for surgical intervention state that in the absence 
of severe neurological deficits, cardiac surgery should be considered urgently [50, 51]. In cases 
Figure 2. An example of septic embolization to the brain (circled) originating from an infected vegetation on the mitral 
valve (arrow) (source: Ref. [29]. Image used under the terms of the Creative Commons Attribution-Noncommercial-
Share Alike 3.0 Unported license).
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of severe ischemic stroke, it is recommended to delay surgery by at least 4 weeks, and with 
hemorrhagic stroke (usually a more severe complication) at least 4 weeks are recommended 
prior to proceeding with cardiac surgery [50].
3.2. Eyes
Septic embolization involving ocular and facial structures is extremely rare. There is, how-
ever, fragmentary case-based evidence for such occurrences. In one example, Dadu et al. [52], 
described SE involving the ophthalmic artery and the inferior muscular artery, resulting in 
diplopia due to medial rectus muscle paralysis. In that particular case, IE of the mitral valve 
was causative. In another rare occurrence, Cumurcu et al. [53], describe a case of a septic 
metastasis to the iris, resulting in iris abscess and endophthalmitis.
3.3. Thyroid
The possibility of SE to the thyroid has been proposed in 1959 by Richie while describing 
acute suppurative thyroiditis in a child [54]. Cabizuca et al. [55], reported an unusual case of 
IE leading to acute thyroiditis, presumably due to septic embolization. Although undoubt-
edly uncommon, the paucity of literature reports in this area is likely due to limited aware-
ness and under-recognition of similar clinical presentations.
4. The thorax
Given the pathophysiologic factors discussed earlier in the chapter, SE of cardiac origin tend 
to follow the pattern of “cardiac output.” Consequently, a generalization can be made that 
the higher the blood flow to a specific organ or anatomic region, the higher the chance of SE 
traveling there. Within the thorax, there are two commonly described types of septic emboli—
those originating on the “left side” of the heart and involving the coronary arterial circulation 
or thoracic aorta [56, 57], and those originating from the “right side” and involving the pul-
monary arterial circuit [58–60].
4.1. Coronary circulation
First described in the 1910s and 1920s, septic coronary embolism continues to be under-recognized 
as a cause of acute coronary ischemia [56]. These types of emboli predominantly originate from 
bacterial valvular vegetations [61]. A high index of clinical suspicion is required because electro-
cardiographic (ECG) and laboratory changes characteristic of myocardial ischemia can easily be 
misinterpreted as being due to more typical coronary artery thrombosis [29]. The diagnosis is 
established through the performance of a comprehensive work-up, including trans-thoracic and 
trans-esophageal echocardiography (TEE), with subsequent angiography as indicated [62, 63]. 
Management may include a variety of both non-interventional and interventional procedures, up 
to and including surgical cardiac revascularization at the time of valve replacement [29].
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4.2. Thoracic aorta
Mycotic aneurysms of the aorta have been described as a consequence of septic emboli 
from infective endocarditis [64]. Clinical management of these lesions is challenging, 
partly due to the presence of active infection within the aneurysm itself, and partly due to 
the associated inflammatory changes and altered (e.g., diminished) structural integrity of 
the involved aorta [65]. Mycotic aortic aneurysms are associated with significant mortal-
ity and complications, including the potential for the development of aortoesophageal or 
aortotracheobronchial fistula [66, 67].
4.3. Pulmonary artery
Pulmonary artery aneurysms (PAA) of infectious etiology are among less frequently seen 
complications of endocarditis [68, 69]. They are similar to mycotic aneurysms, with the main 
difference being the location of occurrence [70]. PAAs (also referred to as Rasmussen’s aneu-
rysms) can be seen in patients with tuberculosis. However, there have been recent cases with 
PAAs being associated with endocarditis [70, 71]. These aneurysms require prompt surgical 
treatment given published mortality rates of approximately 50% [72]. Patients with aneurysms 
that are symptomatic or >6 centimeters in size are candidates for surgery [73]. Data regarding 
surgical treatment are limited; however, recent studies have shown that steel coil embolization 
may be applicable in this setting [70, 74–76]. While PAAs are uncommon in endocarditis, they 
should be considered in patients with IE that present with pulmonary symptoms.
4.4. Pulmonary circulation
Pulmonary SE are relatively common complications of right-sided IE (RSIE). As outlined in 
previous sections, any areas through which large volume of blood transits will be inherently 
susceptible to SE. The pulmonary arterial circuit is no exception in this regard. From an ana-
tomic standpoint, evidence suggests that septic pulmonary emboli (SPE) involve both upper 
and lower lobes, with bilateral upper lobes involved in >70% of patients, and peripheral or 
subpleural zones involved in >90% of cases [58]. Centrally located lesions were noted in only 
about 25% of instances [58]. SPE are distinct from other types of pulmonary emboli because 
of their tendency to form cavitary lesions with air-fluid levels [77]. A significant proportion of 
patients with RSIE are intravenous drug users [78, 79], although there is an increasing num-
ber of patients with SPE who present with IE due to implanted cardiac devices [80, 81]. SPE 
in intravenous drug users can manifest with empyema, and is most likely to be associated 
with endocarditis due to S. aureus infection [82]. Other common complications of SPE include 
pulmonary abscess and pulmonary nodules [77]. If patients with either empyema or a pul-
monary abscess are identified, it is crucial to continue intravenous antibiotics and preform an 
incision and drainage prior to any required valve surgery [83]. Waiting is not recommended 
as a strategy in these patients, mainly because of the risk of further complications associated 
with therapeutic delays [83, 84]. Pulmonary and perivalvular abscess should be suspected in 
intravenous drug users who fail to respond to antibiotic administration [84].
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As with any other type of pulmonary embolism (PE), SPE can be life threatening [85–87]. It 
is important to note that it may be initially difficult to differentiate between the two types of 
PE. Consequently, diagnosis and management requires high levels of clinical suspicion, appropri-
ate diagnostics (e.g., TEE), and immediate treatment (antibiotics, with surgery if indicated). Most 
SPE patients present with constitutional symptoms, dyspnea, chest pain, and cough (including 
hemoptysis) [58]. CT imaging may show the presence of cavitary lesions with an associated “feed-
ing vessel sign,” representing a pulmonary artery coursing directly into the infected area [88].
5. Abdomen and retroperitoneum
5.1. The spleen
Septic embolism to the spleen is well described as a complication of IE [10]. In fact, after SE to the 
central nervous system (>50%), spleen appears to be the second most commonly involved organ 
in terms of frequency (approximately 30%), with some variability across sources of reported data 
[18, 28, 89]. One of most common presentations of SE to the spleen is the appearance of single 
or multiple abscesses [90], including microscopic lesions that were difficult-to-detect until the 
advent of advanced CT imaging [89]. Abdominal CT and MRI are the gold standard for diagnos-
ing splenic abscesses [8]. Infected splenic artery aneurysms attributed to embolic sequelae of IE 
have also been reported [91]. Clinical management involves splenectomy in about 50% of cases, 
with percutaneous drainage indicated for large isolated abscesses and patients who are poor 
surgical candidates [29]. In cases of splenic arterial aneurysm and infarction, prompt surgical 
intervention is recommended. Patients should undergo drainage of the abscess or splenectomy 
prior to any cardiac surgery. This may help prevent further propagation and/or distant spread 
of the systemic infectious process [8, 91]. An example of splenic SE is shown in Figure 3 [92].
5.2. The liver
Septic emboli to the liver are relatively common, occurring in >10% of cases of IE [10]. Similar 
to SE to the spleen, SE to the liver have the potential to evolve over time, coalescing from 
smaller “micro-abscesses” into larger collections [10]. Hepatic abscesses can be present in 
association with either right-sided or left-sided endocarditis [93, 94]; however, it may be dif-
ficult to determine whether the origin of the infection is cardiac or extra-cardiac, especially 
when the involved microorganism has known affinity for both locations [94]. Clinical manage-
ment should follow established guidelines and practices for the treatment of IE and hepatic 
abscesses [29]. Similar to splenic abscess management, hepatic abscess should be drained as 
soon as possible in order to prevent worsening and/or further spread of the systemic infec-
tious process [95].
5.3. The pancreas
Due to its vague clinical presentation, SE to the pancreas has the potential to go unrecognized. 
This is partially because SE to the pancreas often co-occurs with SE to other organs, poten-
tially leading to “clinical masking” of organ-specific symptoms and/or signs [96]. Clinically, 
septic emboli to the pancreas may result in a picture resembling acute pancreatitis, and are 
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usually characterized by leukocytosis, elevated pancreatic enzymes, peri-pancreatic “strand-
ing” on CT scan, and acute abdominal pain [29]. Most often, pancreatic involvement in the 
setting of IE and SE tends to be self-limited [10]. At times, the finding of pseudoaneurysms 
involving adjacent arterial structures may provide a hint that the origin of the observed clini-
cal syndrome is a result of SE [97].
5.4. The kidneys
Similar to the pancreas, SE to the kidneys is most often described in the setting of multi-visceral 
involvement [29]. Overall, renal SE are relatively frequent in the setting of IE, and their mani-
festations include infarcts in 31% of cases and glomerulonephritis in 26% [98]. Of interest, glo-
merulonephritis seen in association with IE has been shown not to feature immune complex 
deposition [98]. The co-occurrence of SE to other organs with arterial “high-flow” characteristics 
is exemplified by cases involving simultaneous cerebral, splenic, renal, and intestinal emboli 
[96]. Clinically, patients with renal SE may be found to have hematuria, glomerulonephritis, 
and evidence of renal failure [10]. Management focuses on preservation of renal function and 
is generally supportive, including antibiotic treatment, end-organ support (if required), and 
percutaneous or open interventions (in cases where abscess drainage is indicated) [98–100].
Etiology of renal injury in patients with IE is not always obvious, especially given the com-
bined effect of cardiac dysfunction, sepsis, and concurrent treatment with potentially neph-
rotoxic antibiotics [98, 101]. Systemic infection can lead to acute tubular necrosis, while 
antibiotic treatment can lead to acute interstitial nephritis [102]. It is important to differentiate 
these conditions from the glomerulonephritis that is seen in IE, with an outline of important 
differentiating factors provided in Table 2.
5.5. The intestines including mesenteric involvement
Given its large surface area and rich vasculature, the bowel receives a significant amount 
of cardiac output and is highly susceptible to SE originating from IE [10, 29]. Fortunately, 
when compared to other organs and organ systems outlined above, arterial distribution to the 
Figure 3. An example of septic embolus to the spleen. In this particular case, the embolus originated from Corynebacterium 
diphtheriae endocarditis (source: Ref. [92]. Image used under the terms of Creative commons Attribution-Noncommercial-
NoDerivs Unported license).
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bowel appears to be less commonly affected (e.g., superior mesenteric artery in 3%, inferior 
mesenteric in <1%) [103]. This may be, at least in part, due to the presence of some degree 
of redundancy within the mesenteric vasculature, as opposed to a lack of such redundancy 
in the kidney or spleen. Occlusion of the superior mesenteric artery by SE is relatively well 
described in the setting of mitral valve endocarditis [104]. Mesenteric pseudoaneurysm attrib-
utable to SE has also been described [105]. In cases of acute arterial occlusion, bowel infarction 
may follow without prompt restoration of adequate blood flow to the involved segment(s) of 
bowel [106].
5.6. Reproductive organs
The involvement of reproductive organs in septic embolic complications is very uncommon. 
However, the authors believe that at least a brief overview of this under-recognized topic is 
warranted. In terms of testicular involvement, symptomatic presentation, including swell-
ing, has been reported in conjunction with right-sided endocarditis [107]. It is thought that 
the  this unusual clinical picture may result from SE [52, 107]. In another case, pneumococcal 
pulmonary valve endocarditis has been circumstantially linked to epididymo-orchitis and a 
scrotal abscess [108], although the directionality of causation may be difficult to prove except 
for the fact that Streptococcus pneumoniae isolated from the epididymo-orchitis is seldom a 
primary cause of scrotal infection. Equally uncommon, ovarian involvement has also been 
reported. In an exceedingly rare case, a female patient presented with a giant pyomyoma 
suggestive of ovarian neoplasm [109]. The origin of this presentation, however, was traced to 
Streptococcus agalactiae endocarditis and deep vein thrombosis of the right external iliac and 
femoral veins [109].
6. Extremities and musculoskeletal system
In general terms, extremity involvement in association with IE represents approximately one-
third of all cases of SE, with clinical manifestations involving the musculature in approximately 
40% cases and bones/joints in >10% of instances [10, 110]. Other than massive embolic events 
involving acute occlusion of arterial flow to an extremity producing significant ischemia, 
symptoms tend to be more “nebulous” in terms of clinical presentation, more self-limited in 
nature, and easily overlooked by clinicians [10, 100]. Pathognomonic signs such as Osler nodes 
Type of kidney 
injury
Glomerular Interstitial Tubular Vascular
Typical causes Bacterial endocarditis 
and vasculitis
Antibiotics Sepsis and hypovolemia Renal ischemia
Cast type Red blood cell casts White blood cell 
casts
Granular casts Tubular epithelial cell 
casts
Clinical 
management
Treatment of 
underlying etiology
Remove inciting 
substance
Hydration and treatment 
of underlying condition
Surgical correction of 
underlying pathology
Table 2. Types of kidney injury, including their associated differentiating characteristics [102].
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and Janeway lesions are rare (2.7 and 1.6% cases, respectively) but highly suggestive of endo-
carditis [111]. Figure 4A shows an example of an Osler node, while Figure 4B demonstrates a 
Janeway lesion [112, 113].
6.1. Acute extremity ischemia
This potentially devastating presentation has been reported in the setting of more severe cases 
of IE, often involving valve replacement [114–116], with some patients experience multiple/
recurring embolic events [114, 115]. In terms of clinical presentation, patients may exhibit a 
broad spectrum of complaints including pain, pallor, poikilothermia, and paresthesias with 
extreme cases threatening the viability of the limb itself [114]. Both surgical and thrombolytic 
management options have been reported [117, 118]. Prompt recognition of the cardiac source 
of SE is critical in preventing further embolic events.
6.2. Septic arthritis
Due to their non-specific nature and general commonality, joint-related complaints can be 
challenging to diagnose and easily misinterpreted. Not infrequently, multiple diagnostic tools 
must be utilized to successfully identify the cardiac source of the patient’s original symptoms 
(and thus the proximal source of infection) [119]. In one case, it was the complaint of septic 
arthritis which led to the ultimate diagnosis of streptococcal endocarditis [120]. Similar to 
other embolic phenomena associated with IE, septic arthritis tends to be a manifestation of 
multi-focal metastases of infectious material [119, 121].
7. Uncommon neurologic presentations
This section will discuss a heterogeneous group of less common manifestations of SE affecting 
the CNS, including extracranial involvement. The paucity of published literature in this broad 
Figure 4. (A, left) An example of an Osler node in a patient with infective endocarditis (source: Ref. [112], image used 
in accordance with the terms of the CC BY 4.0 License); (B, right) Janeway lesions (see arrows) in a patient with aortic 
valve vegetation (source: Ref. [113], image used under the terms of the Creative Commons Attribution-NonCommercial 
4.0 International License).
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topic area is likely due to limited awareness and under-recognition of such clinical presenta-
tions. Within the microcosm of SE associated with IE, approximately 30–40% of events involve 
neurological manifestations [10, 122]. Beyond the more commonly seen complaints (e.g., stroke, 
transient ischemic attack, meningitis, brain abscess) within this subset, less frequently reported 
clinical manifestations may include visual loss, seizures, acute mononeuropathy, and even spi-
nal cord involvement [122–124]. Septic emboli can migrate to the spinal cord, causing segmen-
tal infarction [122, 123]. These exceedingly rare events have the potential to result in severe 
disability and often accompany additional, simultaneous SE to other anatomic regions [10].
8. Miscellaneous considerations
During the past two decades, significant increases have been noted in the number of valvu-
lar repairs, valve replacements, intracardiac devices and hemodialysis catheter placements 
[125–128]. Collectively, these procedures inherently create a small, but significant risk of IE, 
especially in patients with chronic comorbid conditions such as renal insufficiency, diabetes 
and autoimmune diseases [129–131]. Given the potential for major morbidity and mortal-
ity associated with IE in the setting of indwelling intravascular/intracardiac devices, the pri-
mary focus should be on prevention. Within this context, efforts include more selective device 
implantation policies and better modulation of known post-implantation risks [132].
In terms of general diagnostic considerations, numerous guidelines and recommendations 
have been published to date. Although beyond the scope of the current discussion, certain 
aspects of these recommendations warrant a brief mention [133, 134]. One very impor-
tant highlight is the emphasis on prompt echocardiography in cases of suspected IE, with 
TEE recommended if the initial TTE is negative and clinical suspicion remains high [8]. 
Echocardiographic imaging can then be repeated in 3–5 days if clinical symptoms/suspicion 
persist [8]. It is also suggested that patients with vegetations >10 mm in size, embolic events 
while on antibiotic treatment, and patients with >2 embolic events should be evaluated for 
surgical intervention [8]. One unique diagnostic consideration is the inability to use magnetic 
resonance imaging (MRI) in patients with certain types of intravascular devices/implants. 
Amraoui et al. recently described the use of positron emission tomography (PET) as an alter-
native method of identifying foci of SE in patients with implantable cardiac devices, with 
limited success [135].
Treatment options start with intravenous antibiotics, however in certain cases prompt surgi-
cal treatment is necessary. The American Heart Association developed guidelines to assist 
with identification of patients who require prompt surgical intervention [136]. Patients with 
IE who develop decreased left ventricular ejection fraction (LVEF) or a new aortic or mitral 
valve murmur require prompt surgery [50, 136, 137]. Patients with preserved LVEF that are 
stable and adequately managed on medical therapy do not need an immediate corrective sur-
gery [138]. However, a recent study demonstrated that surgical intervention in the setting of 
CHF can reduce mortality from approximately 60–85% to 15–35% when compared to medi-
cal therapy alone [139, 140]. Patients who present with valvular vegetations >10 mm in size, 
or with multiple vegetations on imaging, are likely to benefit from surgery [136]. Another 
important indication for surgery is lack of improvement after 7 days of appropriate antibiotic 
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therapy [136]. Any SE to end organs or associated arterial aneurysms also warrant immedi-
ate surgical evaluation and prompt intervention. As mentioned earlier in the chapter, emboli 
to different anatomic regions may require distinct plans and different timing in terms of 
surgical intervention [50]. The diagnosis of prosthetic valve endocarditis constitutes another 
major indication for surgical intervention. Patients who present within 60 days of discharge 
following the placement of a new prosthetic valve with persistent fevers should be evalu-
ated for the presence of IE, and if proven to harbor such infection should undergo operative 
management. It is important to remember that roughly 25% of prosthetic valve patients may 
be at risk of IE [136, 141].
9. Conclusions
Despite significant clinical research and advances in clinical management, septic embolism 
associated with infectious endocarditis continues to be a diagnostic and therapeutic chal-
lenge. Given the increasing number of intravascular and intracardiac device implantations, as 
well as the greater prevalence of chronic comorbid conditions, it is not surprising that the inci-
dence of both infectious endocarditis and septic embolism has followed suit. In this chapter, 
we outlined general pathophysiologic and anatomic considerations with which all physicians 
should be familiar. This important knowledge should serve to assist providers in maintaining 
a high level of clinical suspicion for potential IE and/or SE. Given the continued high rates of 
associated disability and mortality, more research is needed to better understand and treat 
these “low-frequency, high-impact” events.
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